Skip to main content
. 2023 Oct 10;26(6):507. doi: 10.3892/ol.2023.14094

Figure 3.

Figure 3.

Forest plot of the overall survival in the subgroup of comparison between the Len + TACE group and the TACE monotherapy group. Len, lenvatinib; TACE, transarterial chemoembolization; HBV, hepatitis B virus; AFP, α-fetoprotein; HR, hazard ratio; CI, confidence interval.